Guggenheim Reiterates Buy on Sucampo Pharma (SCMP) Following 1Q Earnings
Tweet Send to a Friend
Guggenheim reiterated a Buy rating and $29.00 price target on Sucampo Pharmaceuticals (NASDAQ: SCMP) following the company's 1Q earnings report ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
